A citation-based method for searching scientific literature

R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
Times Cited: 253







List of co-cited articles
1258 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
40


Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
27

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
376
26

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
779
26

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
409
26

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
24

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
22

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
18

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. J Affect Disord 2013
432
18

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Cristiano A Köhler, Thiago H Freitas, Brendon Stubbs, Michael Maes, Marco Solmi, Nicola Veronese, Nayanna Q de Andrade, Gerwyn Morris, Brisa S Fernandes, André R Brunoni,[...]. Mol Neurobiol 2018
147
17

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
500
17



A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
16


An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Rudolf Uher, Katherine E Tansey, Tracy Dew, Wolfgang Maier, Ole Mors, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Anne Farmer,[...]. Am J Psychiatry 2014
183
12


Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
Ebrahim Haroon, Alexander W Daguanno, Bobbi J Woolwine, David R Goldsmith, Wendy M Baer, Evanthia C Wommack, Jennifer C Felger, Andrew H Miller. Psychoneuroendocrinology 2018
74
16

Treatment-resistant depression and peripheral C-reactive protein.
Samuel R Chamberlain, Jonathan Cavanagh, Peter de Boer, Valeria Mondelli, Declan N C Jones, Wayne C Drevets, Philip J Cowen, Neil A Harrison, Linda Pointon, Carmine M Pariante,[...]. Br J Psychiatry 2019
76
15

Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis.
Lina Wang, Ruzhan Wang, Lanfen Liu, Dongdong Qiao, David S Baldwin, Ruihua Hou. Brain Behav Immun 2019
43
27


Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.
Triin Eller, Veiko Vasar, Jakov Shlik, Eduard Maron. Prog Neuropsychopharmacol Biol Psychiatry 2008
191
11

Evidence for an immune response in major depression: a review and hypothesis.
M Maes. Prog Neuropsychopharmacol Biol Psychiatry 1995
598
11

Cytokine production and treatment response in major depressive disorder.
S Lanquillon, J C Krieg, U Bening-Abu-Shach, H Vedder. Neuropsychopharmacology 2000
436
11

The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery.
Johan Dahl, Heidi Ormstad, Hans Christian D Aass, Ulrik Fredrik Malt, Lil Träskman Bendz, Leiv Sandvik, Lena Brundin, Ole A Andreassen. Psychoneuroendocrinology 2014
171
11

Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression.
F Lamers, N Vogelzangs, K R Merikangas, P de Jonge, A T F Beekman, B W J H Penninx. Mol Psychiatry 2013
361
10

Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.
Manish K Jha, Abu Minhajuddin, Bharathi S Gadad, Tracy Greer, Bruce Grannemann, Abigail Soyombo, Taryn L Mayes, A John Rush, Madhukar H Trivedi. Psychoneuroendocrinology 2017
76
13

The macrophage theory of depression.
R S Smith. Med Hypotheses 1991
512
10



NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder.
Elísabet Alcocer-Gómez, Manuel de Miguel, Nieves Casas-Barquero, Jéssica Núñez-Vasco, José Antonio Sánchez-Alcazar, Ana Fernández-Rodríguez, Mario D Cordero. Brain Behav Immun 2014
188
9

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
396
9

Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients.
Annamaria Cattaneo, Clarissa Ferrari, Rudolf Uher, Luisella Bocchio-Chiavetto, Marco Andrea Riva, Carmine M Pariante. Int J Neuropsychopharmacol 2016
54
16

Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.
J C Felger, Z Li, E Haroon, B J Woolwine, M Y Jung, X Hu, A H Miller. Mol Psychiatry 2016
217
9

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
9


Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
Jia Jia Liu, Ya Bin Wei, Rebecca Strawbridge, Yanping Bao, Suhua Chang, Le Shi, Jianyu Que, Bharathi S Gadad, Madhukar H Trivedi, John R Kelsoe,[...]. Mol Psychiatry 2020
43
20

Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism.
P Zheng, B Zeng, C Zhou, M Liu, Z Fang, X Xu, L Zeng, J Chen, S Fan, X Du,[...]. Mol Psychiatry 2016
572
8

Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.
Floriana S Luppino, Leonore M de Wit, Paul F Bouvy, Theo Stijnen, Pim Cuijpers, Brenda W J H Penninx, Frans G Zitman. Arch Gen Psychiatry 2010
8

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
C L Raison, R Dantzer, K W Kelley, M A Lawson, B J Woolwine, G Vogt, J R Spivey, K Saito, A H Miller. Mol Psychiatry 2010
370
8

Immune system to brain signaling: neuropsychopharmacological implications.
Lucile Capuron, Andrew H Miller. Pharmacol Ther 2011
544
8

A systematic review and meta-analysis of the association between depression and insulin resistance.
Carol Kan, Naomi Silva, Sherita Hill Golden, Ulla Rajala, Markku Timonen, Daniel Stahl, Khalida Ismail. Diabetes Care 2013
173
8


Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Lucile Capuron, Jane F Gumnick, Dominique L Musselman, David H Lawson, Andrea Reemsnyder, Charles B Nemeroff, Andrew H Miller. Neuropsychopharmacology 2002
446
8


Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals.
Marie Kim Wium-Andersen, David Dynnes Ørsted, Sune Fallgaard Nielsen, Børge Grønne Nordestgaard. JAMA Psychiatry 2013
223
8

A detailed examination of cytokine abnormalities in Major Depressive Disorder.
N M Simon, K McNamara, C W Chow, R S Maser, G I Papakostas, M H Pollack, A A Nierenberg, M Fava, K K Wong. Eur Neuropsychopharmacol 2008
187
8

Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.
Ebrahim Haroon, Andrew H Miller, Gerard Sanacora. Neuropsychopharmacology 2017
122
8

Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy.
Knut A Hestad, Sverre Tønseth, Charlotte D Støen, Thor Ueland, Pål Aukrust. J ECT 2003
137
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.